EUVIMEDEUVIMED entdecken
Crossref

Synthesis and In Vivo and In Vitro Properties of 99m Tc-Labeled Fibroblast Activation Protein Inhibitors

Sufan Tang, Zhicong Yang, Jiaqi Nie, Tongtong Wu, Haiyang Li, Yang Liu, Nan Liu iD, Yue Chen iD, Zhijun Zhou iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c01874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Sufan Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan 646000, China. Hauptthemen laut MEDLINE: Membrane Proteins, Gelatinases, Technetium, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Southwest Medical University, National Natural Science Foundation of China, Luzhou-Southwest Medical University Cooperative Application Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast activation protein (FAP) is expressed in more than 90% of tumor-associated fibroblasts in epithelial cancers, providing an excellent target for nuclear medicine diagnostics and therapy. Given the high cost of PET-CT, developing SPECT probes targeting FAP is necessary. A novel FAP inhibitor derived from UAMC1110 was synthesized and conjugated to DOTA via PEG chains. This resulted in a series of inhibitors with good targeting specificity, tumor uptake, and pharmacokinetics. In this study, UAMC1110 derivatives were used as FAP-targeting pharmacophores; PEG chains of varying lengths were employed for pharmacokinetic modification, and HYNIC was used as a bifunctional chelator. The derivatives were labeled with 99mTc using different coligand combinations to explore how PEG chain length and coligand composition affect the in vivo and in vitro properties of 99mTc-labeled FAPI. Four UAMC1110 derivatives (P4, P6, P8, P12) with different PEG chain lengths were synthesized, and a series of hydrophilic 99mTc complexes were prepared. Stability and specificity studies demonstrated that these complexes exhibited good in vitro and in vivo stability and FAP-targeting specificity. In micro-SPECT imaging, these tracers showed rapid tumor accumulation, with 99mTc-TE-P12 and 99mTc-TT-P12 showing promising tumor uptake, low nontarget organ uptake, and high T/NT ratios, indicating potential as SPECT probes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsGelatinasesTechnetiumRadiopharmaceuticalsAnimalsFibroblast Activation Protein AlphaEndopeptidasesHumansSerine EndopeptidasesMiceTissue DistributionTomography, Emission-Computed, Single-PhotonPolyethylene GlycolsCell Line, Tumor

Stichwörter der Autor:innen

99mTcFAPIHYNICcoligand

Substanzen

Fibroblast Activation Protein AlphaMembrane ProteinsGelatinasesEndopeptidasesSerine EndopeptidasesTechnetiumPolyethylene GlycolsRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan 646000, China.
  • Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Jiangyang District, Luzhou, Sichuan 646000, China.
  • Department of Pharmaceutics, School of Pharmacy, Southwest Medical University, Jiangyang District, Luzhou, Sichuan 646000, China.
  • Department of Nuclear Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, China.
  • Academician (Expert) Workstation of Sichuan Province, Jiangyang District, Luzhou, Sichuan 646000, China.

ORCID-Profile: Nan Liu, Yue Chen, Zhijun Zhou

Förderung

  • Southwest Medical University
  • National Natural Science Foundation of China
  • Luzhou-Southwest Medical University Cooperative Application Foundation
  • Sichuan Science and Technology Program

Zitieren

APA

Tang, S., Yang, Z., Nie, J., Wu, T., Li, H., Liu, Y., Liu, N., Chen, Y., & Zhou, Z. (2026). Synthesis and In Vivo and In Vitro Properties of 99m Tc-Labeled Fibroblast Activation Protein Inhibitors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01874

Vancouver

Tang S, Yang Z, Nie J, Wu T, Li H, Liu Y, et al. Synthesis and In Vivo and In Vitro Properties of 99m Tc-Labeled Fibroblast Activation Protein Inhibitors. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01874

BibTeX
@article{Tang2026,
  author = {Tang, Sufan and Yang, Zhicong and Nie, Jiaqi and Wu, Tongtong and Li, Haiyang and Liu, Yang and Liu, Nan and Chen, Yue and Zhou, Zhijun},
  title = {Synthesis and In Vivo and In Vitro Properties of 99m Tc-Labeled Fibroblast Activation Protein Inhibitors},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c01874}
}
Kostenlos starten →